Showing 4901-4910 of 5646 results for "".
- Genentech: Longer-Term Data Reinforce Safety of Satralizumab in Adults and Adolescents With NMOSDhttps://modernod.com/news/genentech-longer-term-data-reinforce-safety-of-satralizumab-in-adults-and-adolescents-with-nmosd/2477813/Genentech will present new pooled pivotal satralizumab safety results for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating central nervous system disorder. These data are being presented at the 6th annual meeting of the European Academy of Neurology (EAN) and
- Verily Seeks to Establish New COVID-19 ‘Baseline’ With Coronavirus Antibody Research Projecthttps://modernod.com/news/verily-seeks-to-establish-new-covid-19-baseline-with-coronavirus-antibody-research-project/2477809/Verily has launched a new clinical research effort focused on COVID-19 antibody testing and exploring the body’s immune response to the novel coronavirus, according to a FierceBiotech
- Reopen Eyecare Website Launches Todayhttps://modernod.com/news/reopen-eyecare-website-launches-today/2477805/Reopeneyecare.com, a new digital platform designed to help eyecare providers navigate the implications of the COVID-19 pandemic on their businesses, launched today. Featuring content specially curated by a taskforce of vision community leaders and sponsored by The Vision Council, the website is i
- Three States Will Use Apple-Google Contact Tracing Technology for Virus Tracking Appshttps://modernod.com/news/three-states-will-use-apple-google-contact-tracing-technology-for-virus-tracking-apps/2477806/Alabama, North Dakota and South Carolina are the first states to commit publicly to using Apple and Google’s contact tracing technology in statewide apps meant to slow the spread of coronavirus, according to a CNBC
- Aldeyra Therapeutics Advances Investigational HSP90 Inhibitor to Clinical Testing for COVID-19https://modernod.com/news/aldeyra-therapeutics-advances-ivestigational-hsp90-inhibitor-to-clinical-testing-for-covid-19/2477799/Aldeyra Therapeutics, which has several drug candidates for the treatment of ocular inflammatory diseases, announced the planned advancement of the investigational new HSP90 inhibitor ADX-1612 to clinical testing for COVID-19, and provided an update on ADX-629, a novel investigational RASP inhibi
- Mayo Clinic, CommonSpirit, and Mass General Feel Hit From COVID-19 in Q1https://modernod.com/news/mayo-clinic-commonspirit-and-mass-general-feel-hit-from-covid-19-in-q1/2477795/Major health systems the Mayo Clinic, CommonSpirit Health, and Mass General Brigham revealed the first details on how the COVID-19 pandemic is hitting them financially, with some systems reporting millions in losses, according to a FierceHealthcare
- Market Scope: Premium IOLs Expected to Drive Market Growth Over the Next 5 Yearshttps://modernod.com/news/market-scope-premium-iols-expected-to-drive-market-growth-over-the-next-5-years/2477796/The revenue contribution of premium IOLs is expected to grow over the next 5 years as the number and different types of IOL designs offered to cataract and refractive patients seeking better visual outcomes increases, according to a Market Scope report. In 2019, premium IOLs accounted a th
- Atia Vision Closes Second Tranche Of $20M In Series D Financinghttps://modernod.com/news/atia-vision-closes-second-tranche-of-20m-in-series-d-financing/2477793/Atia Vision, which is developing of a modular presbyopia-correcting accommodating IOL, announced the closing of its second tranche of a Series D $20M financing. The financing will be used to continue early clinical experience treating cataract patients and support ex
- Kubota Vision Introduces Electronic Eyeglasses to Stop Myopia in Childrenhttps://modernod.com/news/kubota-vision-introduces-electronic-eyeglasses-to-stop-myopia-in-children/2477794/Kubota Vision announced positive clinical results from myopia control tests in humans. Utilizing electronic tabletop optical projection devices that embody Kubota Glasses technology, myopically-defocused images were projected on the peripheral retina of subjects to study if progression of myopia
- Avellino Announces A.C.T.S. Program to Help Eye Care and Other Surgical Practices Protect Patients and Staff From COVID-19https://modernod.com/news/avellino-announces-a-c-t-s-program-to-help-eye-care-and-other-surgical-practices-protect-patients-and-staff-from-covid-19/2477792/Avellino announced the rollout of the new A.C.T.S. Program (Active Coronavirus Testing & Safety) designed to help ophthalmology and other elective surgery and procedure-oriented practices safely reopen and resume care while protecting patients and staff from COVID-19 virus transmission. <